Lercaton

Lercanidipine hydrochloride, the active ingredient in Lercaton, is a calcium channel blocker presented as an oral tablet for oral use. It is indicated for the management of hypertension in adult patients, helping to lower elevated blood pressure and reduce cardiovascular risk.

GNH USA supplies Lercaton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers. Our distribution network ensures timely delivery and regulatory compliance across multiple regions.

Lercaton, a calcium channel blocker, is used primarily in the treatment of hypertension.

- Hypertension: reduces systolic and diastolic blood pressure, aiding in the prevention of cardiovascular complications. - Isolated systolic hypertension: provides effective blood‑pressure control in patients with elevated systolic values, especially in older adults.

Lercaton is generally well tolerated, but a range of adverse reactions have been reported.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Flushing: sensation of warmth, usually on the face or neck. - Peripheral edema: swelling of ankles or feet due to fluid accumulation. - Dizziness: sensation of light‑headedness, especially after standing.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure that may cause fainting. - Myocardial infarction: rare occurrence of heart attack. - Angioedema: swelling of lips, tongue, or throat that can compromise airway.

When prescribing or dispensing Lercaton, consider the following safety measures.

- Blood pressure monitoring: check regularly to avoid excessive hypotension. - Hepatic impairment: use cautiously and consider dose adjustment in patients with liver dysfunction. - Concomitant antihypertensives: assess risk of additive blood‑pressure lowering effects. - Sudden discontinuation: avoid abrupt stop; taper if long‑term therapy is required. - Storage: Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lercaton may interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): can increase plasma concentrations and risk of hypotension. - Other potent vasodilators (e.g., nitroglycerin): may cause additive blood‑pressure lowering effects.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce drug exposure. - Diuretics: monitor electrolytes and blood pressure for synergistic effects. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may blunt antihypertensive response.